Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Myers Scott Dunseth. Director active across 4 companies, notably Viridian Therapeutics, Inc.\DE. Cumulatively, 13 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €268k. History available since 6 February 2023. The latest transaction was disclosed on 30 April 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.